J. Wesseling

发表

Neoadjuvant chemotherapy adaptation and serial MRI response monitoring in ER-positive HER2-negative breast cancer

S. Rodenhuis, L. Rigter, S. Linn, 2013, British Journal of Cancer.

Breast cancer-related deaths according to grade in ductal carcinoma in situ: A Dutch population-based study on patients diagnosed between 1999 and 2012.

L. Koppert, S. Siesling, M. Tilanus-Linthorst, 2018, European journal of cancer.

7 Relevance of Breast Cancer Subtypes in Response Monitoring with 18F-FDG PET/CT During Neoadjuvant Chemotherapy

S. Rodenhuis, E. Rutgers, K. Gilhuijs, 2012 .

[Neoadjuvant systemic therapy in patients with operable primary breast cancer: more benefits than breast-conserving therapy].

S. Rodenhuis, E. Rutgers, S. Linn, 2008, Nederlands tijdschrift voor geneeskunde.

Impact of self-reported comorbidity on physical and mental health status in early symptomatic osteoarthritis: the CHECK (Cohort Hip and Cohort Knee) study.

L. Roorda, S. Bierma-Zeinstra, J. Dekker, 2013, Rheumatology.

Phenotypic expression of double heterozygosity for BRCA1 and BRCA2 germline mutations

R. Eeles, J. Wesseling, J. Oosterwijk, 2005, Journal of Medical Genetics.

Clinical correlates of 'BRCAness' in triple-negative breast cancer of patients receiving adjuvant chemotherapy.

S. Rodenhuis, J. Wesseling, E. Lips, 2012, Annals of oncology : official journal of the European Society for Medical Oncology.

Identifying Trajectories of Pain Severity in Early Symptomatic Knee Osteoarthritis: A 5-year Followup of the Cohort Hip and Cohort Knee (CHECK) Study

S. Bierma-Zeinstra, J. Bijlsma, F. Lafeber, 2015, The Journal of Rheumatology.

Sentinel lymph node biopsy can be omitted in DCIS patients treated with breast conserving therapy

L. Strobbe, E. Rutgers, M. Smidt, 2016, Breast Cancer Research and Treatment.

Triple-negative breast cancer: BRCAness and concordance of clinical features with BRCA1-mutation carriers

S. Rodenhuis, P. Nederlof, J. Wesseling, 2013, British Journal of Cancer.

Discordance in ERα, PR and HER2 receptor status across different distant breast cancer metastases within the same patient.

M. J. van de Vijver, P. Wesseling, J. Wesseling, 2013, Annals of oncology : official journal of the European Society for Medical Oncology.

Indicators of homologous recombination deficiency in breast cancer and association with response to neoadjuvant chemotherapy.

M. J. van de Vijver, S. Rodenhuis, P. Nederlof, 2011, Annals of oncology : official journal of the European Society for Medical Oncology.

Association of primary tumour FDG uptake with clinical, histopathological and molecular characteristics in breast cancer patients scheduled for neoadjuvant chemotherapy

S. Rodenhuis, E. Rutgers, J. Wesseling, 2012, European Journal of Nuclear Medicine and Molecular Imaging.

Pathological non-response to chemotherapy in a neoadjuvant setting of breast cancer: an inter-institutional study

P. V. van Diest, A. Sapino, J. Wesseling, 2014, Breast Cancer Research and Treatment.

Identification of a low-risk subgroup of HER-2-positive breast cancer by the 70-gene prognosis signature

S. Linn, F. Cardoso, Philippe Bédard, 2009, British Journal of Cancer.

Enrichment of high-grade tumors in breast cancer gene expression studies

M. van Seijen, M. Hoogstraat, E. Lips, 2017, Breast Cancer Research and Treatment.

Adjuvant dose-dense doxorubicin-cyclophosphamide versus docetaxel-doxorubicin-cyclophosphamide for high-risk breast cancer: First results of the randomised MATADOR trial (BOOG 2004-04).

S. Linn, M. Kok, J. Wesseling, 2018, European journal of cancer.

Defining knee pain trajectories in early symptomatic knee osteoarthritis in primary care: 5-year results from a nationwide prospective cohort study (CHECK).

S. Bierma-Zeinstra, P. Emans, P. Bindels, 2016, The British journal of general practice : the journal of the Royal College of General Practitioners.

Sarcoidosis mimicking metastatic disease: a case report and review of the literature.

P. Nieboer, J. Wesseling, A. Krikke, 2006, The Netherlands journal of medicine.

The prognostic value of the neoadjuvant response index in triple-negative breast cancer: validation and comparison with pathological complete response as outcome measure

S. Rodenhuis, S. Linn, J. Wesseling, 2015, Breast Cancer Research and Treatment.

Worsening of pain and function over 5 years in individuals with ‘early’ OA is related to structural damage: data from the Osteoarthritis Initiative and CHECK (Cohort Hip & Cohort Knee) study

S. Bierma-Zeinstra, J. Bijlsma, M. Kloppenburg, 2013, Annals of the rheumatic diseases.

Consistency in recognizing microinvasion in breast carcinomas is improved by immunohistochemistry for myoepithelial markers

C. Quinn, P. Regitnig, A. Sapino, 2016, Virchows Archiv.

Prevalence and development of hip and knee osteoarthritis according to American College of Rheumatology criteria in the CHECK cohort

S. Bierma-Zeinstra, R. V. van Rijn, P. Emans, 2019, Arthritis Research & Therapy.

Predictive value of MRI features for development of radiographic osteoarthritis in a cohort of participants with pre-radiographic knee osteoarthritis—the CHECK study

S. Bierma-Zeinstra, M. Reijnierse, R. Wolterbeek, 2017, Rheumatology.

Implementation of trastuzumab in conjunction with adjuvant chemotherapy in the treatment of non-metastatic breast cancer in the Netherlands

J. Wesseling, S. Siesling, V. Tjan-Heijnen, 2011, Breast Cancer Research and Treatment.

Avoidance of Activities in Early Symptomatic Knee Osteoarthritis: Results from the CHECK Cohort

D. Knol, W. Lems, L. Roorda, 2012, Annals of behavioral medicine : a publication of the Society of Behavioral Medicine.

CHECK (Cohort Hip and Cohort Knee): similarities and differences with the Osteoarthritis Initiative

M. Viergever, L. Roorda, M. Boers, 2008, Annals of the rheumatic diseases.

Low cause-specific mortality in women treated for ductal carcinoma in situ of the breast

M. Schmidt, E. Rutgers, F. Leeuwen, 2017 .

Prevalence and predictors of health care use in patients with early hip or knee osteoarthritis: two-year follow-up data from the CHECK cohort.

R. D. de Bie, S. Bierma-Zeinstra, J. Wesseling, 2012, Osteoarthritis and cartilage.

Cohort Profile: Cohort Hip and Cohort Knee (CHECK) study.

M. Viergever, M. Boers, J. Dekker, 2016, International journal of epidemiology.

Defining hip pain trajectories in early symptomatic hip osteoarthritis--5 year results from a nationwide prospective cohort study (CHECK).

S. Bierma-Zeinstra, P. Bindels, J. Wesseling, 2016, Osteoarthritis and cartilage.

Defining knee pain trajectories in early symptomatic knee osteoarthritis in primary care: 5-year results from a nationwide prospective cohort study (CHECK).

S. Bierma-Zeinstra, P. Emans, P. Bindels, 2016, The British journal of general practice : the journal of the Royal College of General Practitioners.

Impact of self-reported comorbidity on physical and mental health status in early symptomatic osteoarthritis: the CHECK (Cohort Hip and Cohort Knee) study.

L. Roorda, S. Bierma-Zeinstra, J. Dekker, 2013, Rheumatology.